866-997-4948(US-Canada Toll Free)

Global Hereditary Angioedema Drug Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Nov 2018

Category :

Pharmaceutical

No. of Pages : 91 Pages

This report studies the global market size of Hereditary Angioedema Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hereditary Angioedema Drug in these regions.
This research report categorizes the global Hereditary Angioedema Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Hereditary Angioedema Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Hereditary Angioedema Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Hereditary Angioedema Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Hereditary Angioedema Drug include
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.

Market Size Split by Type
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
Market Size Split by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Hereditary Angioedema Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Hereditary Angioedema Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hereditary Angioedema Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hereditary Angioedema Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Hereditary Angioedema Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hereditary Angioedema Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hereditary Angioedema Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Hereditary Angioedema Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Type
1.4.2 C1 Esterase Inhibitor
1.4.3 Kallikrein Inhibitor
1.4.4 Selective Bradykinin B2 Receptor Antagonist
1.5 Market by Application
1.5.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hereditary Angioedema Drug Market Size
2.1.1 Global Hereditary Angioedema Drug Revenue 2016-2025
2.1.2 Global Hereditary Angioedema Drug Sales 2016-2025
2.2 Hereditary Angioedema Drug Growth Rate by Regions
2.2.1 Global Hereditary Angioedema Drug Sales by Regions
2.2.2 Global Hereditary Angioedema Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Hereditary Angioedema Drug Sales by Manufacturers
3.1.1 Hereditary Angioedema Drug Sales by Manufacturers
3.1.2 Hereditary Angioedema Drug Sales Market Share by Manufacturers
3.1.3 Global Hereditary Angioedema Drug Market Concentration Ratio (CR5 and HHI)
3.2 Hereditary Angioedema Drug Revenue by Manufacturers
3.2.1 Hereditary Angioedema Drug Revenue by Manufacturers (2016-2018)
3.2.2 Hereditary Angioedema Drug Revenue Share by Manufacturers (2016-2018)
3.3 Hereditary Angioedema Drug Price by Manufacturers
3.4 Hereditary Angioedema Drug Manufacturing Base Distribution, Product Types
3.4.1 Hereditary Angioedema Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hereditary Angioedema Drug Product Category
3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Hereditary Angioedema Drug Sales by Type
4.2 Global Hereditary Angioedema Drug Revenue by Type
4.3 Hereditary Angioedema Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Hereditary Angioedema Drug Breakdown Data by Application

6 North America
6.1 North America Hereditary Angioedema Drug by Countries
6.1.1 North America Hereditary Angioedema Drug Sales by Countries
6.1.2 North America Hereditary Angioedema Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hereditary Angioedema Drug by Type
6.3 North America Hereditary Angioedema Drug by Application
6.4 North America Hereditary Angioedema Drug by Company

7 Europe
7.1 Europe Hereditary Angioedema Drug by Countries
7.1.1 Europe Hereditary Angioedema Drug Sales by Countries
7.1.2 Europe Hereditary Angioedema Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hereditary Angioedema Drug by Type
7.3 Europe Hereditary Angioedema Drug by Application
7.4 Europe Hereditary Angioedema Drug by Company

8 Asia Pacific
8.1 Asia Pacific Hereditary Angioedema Drug by Countries
8.1.1 Asia Pacific Hereditary Angioedema Drug Sales by Countries
8.1.2 Asia Pacific Hereditary Angioedema Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hereditary Angioedema Drug by Type
8.3 Asia Pacific Hereditary Angioedema Drug by Application
8.4 Asia Pacific Hereditary Angioedema Drug by Company

9 Central & South America
9.1 Central & South America Hereditary Angioedema Drug by Countries
9.1.1 Central & South America Hereditary Angioedema Drug Sales by Countries
9.1.2 Central & South America Hereditary Angioedema Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hereditary Angioedema Drug by Type
9.3 Central & South America Hereditary Angioedema Drug by Application
9.4 Central & South America Hereditary Angioedema Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Hereditary Angioedema Drug by Countries
10.1.1 Middle East and Africa Hereditary Angioedema Drug Sales by Countries
10.1.2 Middle East and Africa Hereditary Angioedema Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hereditary Angioedema Drug by Type
10.3 Middle East and Africa Hereditary Angioedema Drug by Application
10.4 Middle East and Africa Hereditary Angioedema Drug by Company

11 Company Profiles
11.1 Pharming Group NV
11.1.1 Pharming Group NV Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Hereditary Angioedema Drug
11.1.4 Hereditary Angioedema Drug Product Description
11.1.5 Recent Development
11.2 Shire plc
11.2.1 Shire plc Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Hereditary Angioedema Drug
11.2.4 Hereditary Angioedema Drug Product Description
11.2.5 Recent Development
11.3 CSL Limited
11.3.1 CSL Limited Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Hereditary Angioedema Drug
11.3.4 Hereditary Angioedema Drug Product Description
11.3.5 Recent Development
11.4 iBio Inc.
11.4.1 iBio Inc. Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Hereditary Angioedema Drug
11.4.4 Hereditary Angioedema Drug Product Description
11.4.5 Recent Development
11.5 BioCryst Pharmaceuticals, Inc.
11.5.1 BioCryst Pharmaceuticals, Inc. Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Hereditary Angioedema Drug
11.5.4 Hereditary Angioedema Drug Product Description
11.5.5 Recent Development
11.6 Ionis Pharmaceuticals, Inc.
11.6.1 Ionis Pharmaceuticals, Inc. Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Hereditary Angioedema Drug
11.6.4 Hereditary Angioedema Drug Product Description
11.6.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Hereditary Angioedema Drug Raw Material
13.1.2 Hereditary Angioedema Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Hereditary Angioedema Drug
Figure Global Hereditary Angioedema Drug Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Hereditary Angioedema Drug Production Market Share by Types (Product Category) in 2017
Figure C1 Esterase Inhibitor Product Picture
Table Major Manufacturers of C1 Esterase Inhibitor
Figure Kallikrein Inhibitor Product Picture
Table Major Manufacturers of Kallikrein Inhibitor
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist
Table Global Hereditary Angioedema Drug Market Size Growth Rate by Application 2018-2025 (MT)
Figure Retail Pharmacies
Figure Hospital Pharmacies
Figure Online Pharmacies
Figure Hereditary Angioedema Drug Report Years Considered
Figure Global Hereditary Angioedema Drug Market Size 2016-2025 (Million US$)
Figure Global Hereditary Angioedema Drug Sales 2016-2025 (MT)
Table Global Hereditary Angioedema Drug Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Hereditary Angioedema Drug Sales by Regions 2016-2025 (MT)
Table Global Hereditary Angioedema Drug Sales Market Share by Regions 2016-2025
Figure Global Hereditary Angioedema Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Hereditary Angioedema Drug Sales Market Share by Regions
Table Global Hereditary Angioedema Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Hereditary Angioedema Drug Revenue Market Share by Regions 2016-2025
Figure Global Hereditary Angioedema Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Hereditary Angioedema Drug Revenue Market Share by Regions
Table Global Hereditary Angioedema Drug Sales by Manufacturers (2016-2018) (MT)
Table Global Hereditary Angioedema Drug Sales Share by Manufacturers (2016-2018)
Figure Global Hereditary Angioedema Drug Sales Share by Manufacturers in 2017
Table Hereditary Angioedema Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Hereditary Angioedema Drug Revenue Share by Manufacturers (2016-2018)
Figure Hereditary Angioedema Drug Value Share by Manufacturers in 2017
Table Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Hereditary Angioedema Drug Price (2016-2018) (USD/Kg)
Table Hereditary Angioedema Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Hereditary Angioedema Drug Product Category
Table Date of International Manufacturers Enter into Hereditary Angioedema Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Hereditary Angioedema Drug Sales by Type (2016-2025) (MT)
Table Global Hereditary Angioedema Drug Sales Share by Type (2016-2025)
Figure Global Hereditary Angioedema Drug Sales Market Share by Type (2016-2025)
Figure Global Hereditary Angioedema Drug Sales Market Share by Type in 2017
Table Global Hereditary Angioedema Drug Revenue by Type (2016-2025) (Million US$)
Table Global Hereditary Angioedema Drug Revenue Share by Type (2016-2025)
Figure Global Hereditary Angioedema Drug Revenue Market Share by Type (2016-2025)
Figure Global Hereditary Angioedema Drug Revenue Market Share by Type in 2017
Table Hereditary Angioedema Drug Price by Type 2013-2018 (USD/Kg)
Table Global Hereditary Angioedema Drug Sales by Application (2016-2025) (MT)
Table Global Hereditary Angioedema Drug Sales Share by Application (2016-2025)
Figure Global Sales Hereditary Angioedema Drug Market Share by Application (2016-2025)
Figure Global Sales Hereditary Angioedema Drug Market Share by Application (2016-2025)
Figure North America Hereditary Angioedema Drug Sales Growth Rate 2016-2025 (MT)
Figure North America Hereditary Angioedema Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Hereditary Angioedema Drug Sales by Countries (2016-2025) (MT)
Table North America Hereditary Angioedema Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Hereditary Angioedema Drug Sales Market Share by Countries
Table North America Hereditary Angioedema Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Hereditary Angioedema Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Hereditary Angioedema Drug Revenue Market Share by Countries
Figure United States Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure United States Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Canada Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Mexico Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Hereditary Angioedema Drug Sales by Type (2016-2025) (MT)
Table North America Hereditary Angioedema Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Hereditary Angioedema Drug Market Share by Type
Table North America Hereditary Angioedema Drug Sales by Application (2016-2025) (MT)
Table North America Hereditary Angioedema Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Hereditary Angioedema Drug Market Share by Application
Table North America Hereditary Angioedema Drug Sales by Company (2016-2018) (MT)
Table North America Hereditary Angioedema Drug Sales Market Share by Company (2016-2018)
Figure North America Hereditary Angioedema Drug Sales Market Share by Company in 2017
Figure Europe Hereditary Angioedema Drug Sales Growth Rate 2016-2025 (MT)
Figure Europe Hereditary Angioedema Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Hereditary Angioedema Drug Sales by Countries (2016-2025) (MT)
Table Europe Hereditary Angioedema Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Hereditary Angioedema Drug Sales Market Share by Countries
Table Europe Hereditary Angioedema Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Hereditary Angioedema Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Hereditary Angioedema Drug Revenue Market Share by Countries
Figure Germany Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Germany Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (MT)
Figure France Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure France Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (MT)
Figure UK Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure UK Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Italy Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Russia Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Hereditary Angioedema Drug Sales by Type (2016-2025) (MT)
Table Europe Hereditary Angioedema Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Hereditary Angioedema Drug Market Share by Type
Table Europe Hereditary Angioedema Drug Sales by Application (2016-2025) (MT)
Table Europe Hereditary Angioedema Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Hereditary Angioedema Drug Market Share by Application
Table Europe Hereditary Angioedema Drug Sales by Company (2016-2018) (MT)
Table Europe Hereditary Angioedema Drug Sales Market Share by Company (2016-2018)
Figure Europe Hereditary Angioedema Drug Sales Market Share by Company in 2017
Figure Asia Pacific Hereditary Angioedema Drug Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Hereditary Angioedema Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Hereditary Angioedema Drug Sales by Countries (2016-2025) (MT)
Table Asia Pacific Hereditary Angioedema Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Hereditary Angioedema Drug Sales Market Share by Countries
Table Asia Pacific Hereditary Angioedema Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Countries
Figure China Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure China Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Japan Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Korea Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure India Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Australia Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Philippines Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Thailand Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Singapore Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Hereditary Angioedema Drug Sales by Type (2016-2025) (MT)
Table Asia Pacific Hereditary Angioedema Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Hereditary Angioedema Drug Market Share by Type
Table Asia Pacific Hereditary Angioedema Drug Sales by Application (2016-2025) (MT)
Table Asia Pacific Hereditary Angioedema Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Hereditary Angioedema Drug Market Share by Application
Table Asia Pacific Hereditary Angioedema Drug Sales by Company (2016-2018) (MT)
Table Asia Pacific Hereditary Angioedema Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Hereditary Angioedema Drug Sales Market Share by Company in 2017
Figure Central & South America Hereditary Angioedema Drug Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Hereditary Angioedema Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Hereditary Angioedema Drug Sales by Countries (2016-2025) (MT)
Table Central & South America Hereditary Angioedema Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Hereditary Angioedema Drug Sales Market Share by Countries
Table Central & South America Hereditary Angioedema Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Hereditary Angioedema Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Hereditary Angioedema Drug Revenue Market Share by Countries
Figure Brazil Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Brazil Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Argentina Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Hereditary Angioedema Drug Sales by Type (2016-2025) (MT)
Table Central & South America Hereditary Angioedema Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Hereditary Angioedema Drug Market Share by Type
Table Central & South America Hereditary Angioedema Drug Sales by Application (2016-2025) (MT)
Table Central & South America Hereditary Angioedema Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Hereditary Angioedema Drug Market Share by Application
Table Central & South America Hereditary Angioedema Drug Sales by Company (2016-2018) (MT)
Table Central & South America Hereditary Angioedema Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Hereditary Angioedema Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Hereditary Angioedema Drug Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Hereditary Angioedema Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Hereditary Angioedema Drug Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Countries
Table Middle East and Africa Hereditary Angioedema Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Countries
Figure GCC Countries Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Turkey Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure Egypt Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Hereditary Angioedema Drug Sales Growth Rate (2016-2025) (MT)
Figure South Africa Hereditary Angioedema Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Hereditary Angioedema Drug Sales by Type (2016-2025) (MT)
Table Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Hereditary Angioedema Drug Market Share by Type
Table Middle East and Africa Hereditary Angioedema Drug Sales by Application (2016-2025) (MT)
Table Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Hereditary Angioedema Drug Market Share by Application
Table Middle East and Africa Hereditary Angioedema Drug Sales by Company (2016-2018) (MT)
Table Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Company in 2017
Table Pharming Group NV Company Details
Table Pharming Group NV Hereditary Angioedema Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Pharming Group NV Recent Development
Table Shire plc Company Details
Table Shire plc Hereditary Angioedema Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Shire plc Recent Development
Table CSL Limited Company Details
Table CSL Limited Hereditary Angioedema Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table CSL Limited Recent Development
Table iBio Inc. Company Details
Table iBio Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table iBio Inc. Recent Development
Table BioCryst Pharmaceuticals, Inc. Company Details
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table BioCryst Pharmaceuticals, Inc. Recent Development
Table Ionis Pharmaceuticals, Inc. Company Details
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Ionis Pharmaceuticals, Inc. Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Hereditary Angioedema Drug Value Chain
Table Typical Suppliers of Key Hereditary Angioedema Drug Raw Material
Table Hereditary Angioedema Drug Customers List
Table Hereditary Angioedema Drug Sales Channels
Table Hereditary Angioedema Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *